HFCWO is an airway clearance therapy used to loosen, thin, and mobilize airway secretions.
SmartVest can help to prevent the onset of inflammation and recurring respiratory infections that can further damage airways.
SmartVest is an HFCWO therapy device with published outcome studies that demonstrate its efficacy in treating bronchiectasis and stabilizing lung function.1-3
Bronchiectasis is a chronic pulmonary condition that permanently damages the airways, causing repeated respiratory infections and difficulty breathing.
By using SmartVest, patients experienced a reduction in:
Other vest therapy brands on the market just can’t say the same.
Through 30+ years of product research, development, and manufacturing, SmartVest has helped people with impaired airway clearance live life to its fullest potential.
Manufactured in our home state of Minnesota, SmartVest offers more than two decades of demonstrated results, unparalleled customer support, and new advances in airway clearance technology.
A first-of-its-kind, independent study analyzed the effectiveness of HFCWO therapy as part of a treatment algorithm.
The study found that early initiation of SmartVest proved effective in significantly reducing hospitalizations and stabilized key lung function parameters.1
Citations:
Powner, Jordan, et al. Employment of an Algorithm of Care Including Chest Physiotherapy Results in Reduced Hospitalizations and Stability of Lung Function in Bronchiectasis. BMC Pulmonary Medicine, BioMed Central. 25 Apr. 2019.
Sievert C, et al. Using High Frequency Chest Wall Oscillation in a Bronchiectasis Patient Population: An Outcomes-Based Case Review. Respiratory Therapy Journal. 2016;11(4): 34–38.